Granules India informs about disclosure

23 Jul 2022 Evaluate

Granules India has informed that the US FDA has completed an inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, the USA on 22nd July 2022 with six (6) observations. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

587.45 6.60 (1.14%)
11-Mar-2026 13:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.50
Dr. Reddys Lab 1327.40
Cipla 1335.00
Zydus Lifesciences 926.80
Lupin 2362.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×